MolPort-002-130-141

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

31 Suppliers, 19 USDMF, 14 CEP/COS, 6 EU WC, 5 NDC API, 16 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

5 Suppliers

5 Suppliers

DOSSIERs // Finished Dosage Forms

172 Dossiers, 118 FDA Orange Book, 5 Europe, 19 Canada, 6 Australia, 6 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG, TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG, TABLET;ORAL - 2MG, TABLET;ORAL - 3MG, TABLET;ORAL - 4MG, TABLET;ORAL - 5MG, TABLET;ORAL - 6MG, TABLET;ORAL - 7.5MG

RELATED EXCIPIENT COMPANIES

Suppliers, 37 Kerry, 21 SPI Pharma, 16 Roquette, 14 Microlex e.U, 10 Gangwal Healthcare, 10 BASF, 10 Sigachi Industries, 10 Corel Pharma Chem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Seppic, 7 Gangwal Chemicals, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 DFE Pharma, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 3 Kima Chemical, 3 Prachin Chemical, 3 Vasa Pharmachem, 2 The Dow Chemical Company, 2 Rochem International Inc, 2 Actylis, 2 Pharmatrans-Sanaq, 1 Ulanqab Kema New Material, 1 ACG Worldwide, 1 Qualicaps, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 DKSH, 1 Pfanstiehl, 1 Jai Radhe Sales, 1 Nanjing Well Pharmaceutical

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 37 Direct Compression, 23 Controlled & Modified Release, 23 Granulation, 21 Disintegrants & Superdisintegrants, 17 Co-Processed Excipients, 16 Thickeners and Stabilizers, 16 Chewable & Orodispersible Aids, 15 Taste Masking, 11 Lubricants & Glidants, 8 Solubilizers, 8 Parenteral, 6 Film Formers & Plasticizers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 21 Finished Drug Prices

MARKET PLACE

9 APIs, 12 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 2 Analytical Solutions, 2 EDQM Standards, 1 Other Ref. Standards

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 11 News

Australian Register of Therapeutic Goods list of Approved Drug Products containing MolPort-002-130-141. Original Data : Therapeutic Goods Administration Website

MolPort-002-130-141

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

31 Suppliers

19 USDMF

14 CEP/COS

6 EU WC

5 NDC API

16 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

5 Suppliers

DOSSIERs // Finished Dosage Forms

172 Dossiers

118 FDA Orange Book

5 Europe

19 Canada

6 Australia

6 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG

TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 2.5MG

TABLET;ORAL - 2MG

TABLET;ORAL - 3MG

TABLET;ORAL - 4MG

TABLET;ORAL - 5MG

TABLET;ORAL - 6MG

TABLET;ORAL - 7.5MG

RELATED EXCIPIENT COMPANIES

Suppliers

37 Kerry

21 SPI Pharma

16 Roquette

14 Microlex e.U

10 Gangwal Healthcare

10 BASF

10 Sigachi Industries

10 Corel Pharma Chem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Seppic

7 Gangwal Chemicals

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 DFE Pharma

5 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

3 Kima Chemical

3 Prachin Chemical

3 Vasa Pharmachem

2 The Dow Chemical Company

2 Rochem International Inc

2 Actylis

2 Pharmatrans-Sanaq

1 Ulanqab Kema New Material

1 ACG Worldwide

1 Qualicaps

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Boai NKY Pharmaceuticals Ltd

1 DKSH

1 Pfanstiehl

1 Jai Radhe Sales

1 Nanjing Well Pharmaceutical

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders

40 Coating Systems & Additives

37 Direct Compression

23 Controlled & Modified Release

23 Granulation

TABLET;ORAL - 1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons